Navigation Links
Centice Corporation Enhances the PASS Rx System with its Version 3.0 Software Update
Date:2/1/2010

Centice Corporation, a pioneer in drug verification and safety products, announced today that it has released a new version of its PASS Rx system.

Morrisville, NC (PRWEB) February 1, 2010 -- Centice Corporation, a pioneer in drug verification and safety products, announced today that it has released a new version of its PASS Rx system. PASS Rx scientifically verifies, within a closed pill vial, the majority of the oral solid medications to improve the dispense accuracy in pharmacies. PASS Rx is the most reliable solution to allow pharmacies to protect themselves and their patients.

According to a 2006 report from the Institute of Medicine, at least 1.5 million Americans are injured by medication errors every year, many due to the wrong drug or strength being dispensed. Another study states that about four drug or strength errors occur per day in a pharmacy with a daily volume of 250 prescriptions. Manual verification can be largely subjective; Centice can help.

The new enhancements in Version 3.0 include an increased database size to over two thousand unique medications, which equates to more than 20,000 NDCs. In addition, PASS Rx can now be used to perform accuracy scans for barcode-based verification of non-vial dispensed drugs. Combined, these enhancements enable PASS Rx to cover nearly 100% of the workflow in retail and hospital outpatient pharmacies.

After multiple customer focus groups were conducted, the new user interface was also improved to provide the pharmacist or technician with easy to understand results on the display. The user interface continues to provide Medi-Span® drug images and descriptions for the added value of visual verification.

Centice Corporation provides its customers with storage and reporting capabilities to enhance quality control in the pharmacy. Anything scanned and/or analyzed through the PASS Rx system is captured for future reporting on how many scripts were filled, how many were run through PASS Rx and how many errors have been caught.

Periodic updates are provided remotely so that Centice may provide its customers with the most up-to-date information as drugs are added or removed from the library and for faster customer service.

”We are thrilled to offer our pharmacy customers an improved solution that will assist them in increasing their quality and efficiency, ultimately allowing them to do what they do best, spend more time consulting with their patients,” said Scott Albert, Chairman of the Board and Chief Executive Officer of Centice.

About Centice Corporation
Centice, founded in 2004 and headquartered in Morrisville, NC, is commercializing patented and patent-pending computational sensor and machine vision technology. The PASS Rx® pharmaceutical authentication sensor system improves the verification process for dispensed medications, thereby improving quality and optimizing workflow in the pharmacy. The company has received venture capital investments from The Aurora Funds, Inc., Novak Biddle Venture Partners, S-Group Direct Investments Ltd, Innovation Ventures LP, Fulcrum Financial Group, L.P. and other private investors. More information on Centice can be found at www.centice.com.

# # #

Read the full story at http://www.prweb.com/releases/2010/02/prweb3537194.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Providence Service Corporation to Present at the Jefferies 2010 Global Healthcare Services Conference on Monday, January 25th
2. Centage Corporation Reports 16% Growth in 2009; Planning Maestro, Business Performance Management Software Implementations on the Rise
3. Hepregen Corporation Receives SBIR Phase II Grant from the National Science Foundation and Presents Corporate Update at OneMed Forum
4. United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders
5. Amerigroup Corporation to Discuss Fourth Quarter and 2009 Year-End Earnings on February 19
6. Providence Service Corporation Comments on Senate Health Care Reform
7. Triple-S Management Corporation to Present at J. P. Morgan Healthcare Conference
8. Service Corporation International Extends Offer for Keystone North America Inc.
9. Atrion Networking Corporation Selects Ruckus Wireless for Reliable as Wire Enterprise Wi-Fi Service
10. Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees Benefit Selection Process
11. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Centice Corporation Enhances the PASS Rx System with its Version 3.0 Software Update  
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, ... at Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of ... acupuncturists to help patients realize their family building goals. Acupuncture helps fertility ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a ... to the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation ... she can for this country. , Nancy attributes her patriotic nature to her WWII ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Fred Rides a Train” ... Day that follows. , “Fred Rides a Train” is the creation of published ... stories since her teen years in Michigan. The "Fred, the Dog" series is her ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... fifth annual Business Architecture Innovation Summit in Reston, VA on March 21-22, 2017. ... will share a range of experiences from a cross-section of industries such as ...
(Date:12/7/2016)... ... December 07, 2016 , ... NuevaCare, a leading home ... is proud to announce new city-specific pages as part of its ambitious website relaunch. ... they often look, first, for local agencies serving their city. The new site has ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)...  Alopexx Oncology, LLC announced data from a Phase ... (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal antibody. ... cells as Rituxan and maintains the activities of both ... in tumor targeting, engagement of the immune system, and ... the study (abstract #95954) were presented at the 58 ...
(Date:12/6/2016)... -- Diabetes & Obesity Drug Development Pipeline Review, 2016 ... is currently dominated by therapeutics indicated for type 1 ... and the majority of the pipeline, in terms of ... these indications. While products indicated for obesity do not ... large number of these products in the pipeline, with ...
(Date:12/6/2016)... The pen needles market is projected to reach USD ... 2016, growing at a CAGR of 11.2% during the ... years, the pen needles market has witnessed various technological ... for safety injections in the healthcare industry. These advancements ... with an aim to reduce pain, increase comfort, and ...
Breaking Medicine Technology: